Showing 501-510 of 2910 results for "".
Identification, Management, and Prevention of Polypharmacy in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/identification-management-and-prevention-of-polypharmacy-in-multiple-sclerosis/32088/Rational prescription practices in multiple sclerosis treatment are key to the prevention and mitigation of polypharmacy.Updates in Bruton Tyrosine Kinase Inhibition for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/updates-in-bruton-tyrosine-kinase-inhibition-for-multiple-sclerosis/31975/Ongoing clinical trials will elucidate potential advantages and safety of these novel medications for future treatment of multiple sclerosis.Occipital Neuralgia & Cervicogenic Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/occipital-neuralgia-cervicogenic-headache/31787/Occipital neuralgia and cervicogenic headache have similar anatomy and treatment.Inpatient Rehabilitation Following Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/inpatient-rehabilitation-following-traumatic-brain-injury/31989/Unique care and benefits of inpatient rehabilitation facilities compared with other care settingsCerebral Venous Thrombosis Presenting as Recurrent Transient Ischemic Attack–Like Episodes
https://practicalneurology.com/diseases-diagnoses/stroke/cerebral-venous-thrombosis-presenting-as-recurrent-transient-ischemic-attack-like-episodes/32194/The authors describe a rare occurrence of multiple transient ischemic attack–like episodes as the presenting symptom of cerebral venous thrombosis.Health Care Disparities in Alzheimer Disease Diagnosis and the Use of Amyloid-Targeting Treatments
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/health-care-disparities-in-alzheimer-disease-diagnosis-and-the-use-of-amyloid-targeting-treatments/36240/Disparities in Alzheimer disease care persist, and people from underrepresented racial, ethnic, or socioeconomic groups face considerable barriers to early diagnosis and access to disease-modifying anti-amyloid therapies.Imaging Outcome Measures in Neuromuscular Diseases
https://practicalneurology.com/diseases-diagnoses/neuromuscular/imaging-outcome-measures-in-neuromuscular-diseases/35584/MRI is an important tool for assessing muscle and nerve changes in neuromuscular disease and is helpful to clinicians in monitoring therapeutic outcomes.Single Isolated Concussion Part I: Definitions, Classification, and Prognosis
https://practicalneurology.com/diseases-diagnoses/tbi/single-isolated-concussion-part-i-definitions-classification-and-prognosis/30268/Providing sound advice after a single isolated concussion.Uncertainties About Cardiac Monitoring After Cryptogenic Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/uncertainties-about-cardiac-monitoring-after-cryptogenic-stroke/30442/Despite a bevy of options to manage atrial fibrillation, many questions remain unanswered regarding the utility of monitoring and anticoagulation.Impaired Driving Related to Medications and Neurological Diagnoses
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/impaired-driving-related-to-medications-and-neurological-diagnoses/30686/Researchers investigated the degree to which various common agents, including benzodiazepines and non-benzodiazepine hypnotics, may affect driving ability. Therapy selection and patient counseling are key to safe use.